{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05766384",
            "orgStudyIdInfo": {
                "id": "STUDY00149906"
            },
            "organization": {
                "fullName": "University of Kansas Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "Hyperpolarized 129Xe MRI Lung Health Cohort",
            "officialTitle": "Hyperpolarized 129Xe MRI to Identify Structural Determinants of Low Lung Function and Respiratory Symptoms in Young Adults From the Lung Health Cohort",
            "acronym": "XeLHC",
            "therapeuticArea": [
                "Other"
            ],
            "study": "hyperpolarized-mri-lung-health-cohort"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-30",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-03-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-03-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-03-01",
            "studyFirstSubmitQcDate": "2023-03-01",
            "studyFirstPostDateStruct": {
                "date": "2023-03-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-06",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-08",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Peter J. Niedbalski, PhD",
                "investigatorTitle": "Research Assistant Professor",
                "investigatorAffiliation": "University of Kansas Medical Center"
            },
            "leadSponsor": {
                "name": "University of Kansas Medical Center",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Johns Hopkins University",
                    "class": "OTHER"
                },
                {
                    "name": "University of Iowa",
                    "class": "OTHER"
                },
                {
                    "name": "Duke University",
                    "class": "OTHER"
                },
                {
                    "name": "University of Illinois at Chicago",
                    "class": "OTHER"
                },
                {
                    "name": "Baylor College of Medicine",
                    "class": "OTHER"
                },
                {
                    "name": "M.D. Anderson Cancer Center",
                    "class": "OTHER"
                },
                {
                    "name": "Temple University",
                    "class": "OTHER"
                },
                {
                    "name": "University of Pennsylvania",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "A subset of young adults participating in the American Lung Association (ALA) Lung Health Cohort (LHC) will be imaged using Hyperpolarized 129Xe MRI to assess lung structure and function. Images will be used to improve the understanding of lung health and early lung abnormalities that may lead to chronic lung disease."
        },
        "conditionsModule": {
            "conditions": [
                "Healthy"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "CROSS_SECTIONAL"
            },
            "enrollmentInfo": {
                "count": 260,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Hyperpolarized Xe129",
                    "description": "Inhaled hyperpolarized 129Xe used as a signal agent for MRI of the lungs.",
                    "otherNames": [
                        "Xenon, 129Xe, HP Xenon"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Xe-MRI Apparent Diffusion Coefficient",
                    "description": "Correlation of Xe-MRI with FEV1/FVC and other measures of lung function",
                    "timeFrame": "At baseline imaging timepoint"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Is enrolled in the American Lung Association Lung Health Cohort Study.\n* Has completed CT imaging for the LHC study within 2 years of the scheduled Xe-MRI date.\n\nExclusion Criteria:\n\n* Pacemaker, internal defibrillator or other implanted electronic devices or any standard MRI contraindications (e.g., claustrophobia, \\> 140 cm shoulder circumference, dependent on weight distribution).\n* Is pregnant or breastfeeding\n* Oxygen saturation (SpO2) \\<88% on room air or with supplemental oxygen.",
            "sex": "ALL",
            "minimumAge": "25 Years",
            "maximumAge": "35 Years",
            "stdAges": [
                "ADULT"
            ],
            "studyPopulation": "Participants enrolled in the Lung Health Cohort at participating Airways Clinical Research Centers. The investigators target to enroll approximately 50% females and enroll approximately 1/3 low socioeconomic status (SES) participants, 1/3 middle SES, and 1/3 high SES. The target for the population demographics is to match those of the larger, LHC parent study.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Adam Ruff",
                    "role": "CONTACT",
                    "phone": "913-574-3932",
                    "email": "aruff@kumc.edu"
                },
                {
                    "name": "Cristal Monge",
                    "role": "CONTACT",
                    "email": "chernandez@kumc.edu"
                }
            ],
            "locations": [
                {
                    "facility": "University of Kansas Medical Center",
                    "status": "RECRUITING",
                    "city": "Kansas City",
                    "state": "Kansas",
                    "zip": "66160",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Cristal Monge",
                            "role": "CONTACT",
                            "phone": "913-945-9399",
                            "email": "chernandez@kumc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.11417,
                        "lon": -94.62746
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Deidentified imaging data will be made available to researchers by publishing on a data sharing site. Images will be made available upon completion of the study and publication of the summary paper.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "ICF",
                "ANALYTIC_CODE"
            ],
            "timeFrame": "Data will be made available indefinitely upon completion of the study (anticipated 3/31/2028)"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M15623",
                    "name": "Signs and Symptoms, Respiratory",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014978",
                    "term": "Xenon"
                }
            ],
            "ancestors": [
                {
                    "id": "D000018685",
                    "term": "Anesthetics, Inhalation"
                },
                {
                    "id": "D000018681",
                    "term": "Anesthetics, General"
                },
                {
                    "id": "D000000777",
                    "term": "Anesthetics"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17715",
                    "name": "Xenon",
                    "asFound": "STEMI",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4107",
                    "name": "Anesthetics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20765",
                    "name": "Anesthetics, Inhalation",
                    "relevance": "LOW"
                },
                {
                    "id": "M20761",
                    "name": "Anesthetics, General",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}